Suki Kilgore
"Florida Veterinary Specialists and Cancer Treatment Center believes in the bond that exists between people and their pets. Knowing that your pet is ill can be a scary experience. We are here to provide you options for your pet's care."
Erick Mears, DVM
Diplomate ACVIM
Internal Medicine
|
|
|
Mast Cell Tumor Clinical Trial - Currently Unavailable
|
|
We are currently recruiting dogs diagnosed with either grade II or grade III mast cell tumors for a clinical study investigating the safety and efficacy of a new drug.
Inclusion Criteria
- Dogs, regardless of the breed and sex.
- Owner written informed consent.
- Dogs presenting one or several histologically diagnosed measurable grade II (intermediate) or grade III (poorly differentiated) MCTs, and either recurrence after failure of surgery, or presence of non-resectable tumor.
Exclusion Criteria
- Lactating/pregnant bitches, dogs intended for breeding.
- Dogs under 6 months age.
- Dog weight strictly under 3.3 kg.
- Chemotherapy, including corticosteroids, with 2 weeks of treatment initiation.
- Surgical removal within 2 weeks of treatment initiation and/or incompletely healed surgical incisions prior to treatment initiation.
- Radiation therapy within 6 weeks of treatment initiation.
- Severe renal insufficiency or significant renal impairment.
- Presence of gastrointestinal bleeding assessed by clinical signs.
- Presence of internal metastasis.
- Presence of lymph nodes involvement.
- Absolute neutrophil count <3000 / mm3
- Other serious diseases (life expectancy less than 3 months)
- Liver transaminases >2 x N upper limit of normal and/or abnormal liver structure as assessed by ultrasound.
Back
|
|
